======= ASUN ======= == Gene Information == * **Official Symbol**: INTS13 * **Official Name**: integrator complex subunit 13 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55726|55726]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NVM9|Q9NVM9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ASUN&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ASUN|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615079|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Crucial regulator of the mitotic cell cycle and development. At prophase, required for dynein anchoring to the nuclear envelope important for proper centrosome-nucleus coupling. At G2/M phase, may be required for proper spindle formation and execution of cytokinesis. Probable component of the Integrator (INT) complex, a complex involved in the small nuclear RNAs (snRNA) U1 and U2 transcription and in their 3'-box-dependent processing (PubMed:23904267). {ECO:0000269|PubMed:15737938, ECO:0000269|PubMed:23097494, ECO:0000269|PubMed:23904267, ECO:0000305|PubMed:23097494, ECO:0000305|PubMed:23904267}. |DUF2151| |protein localization to nuclear envelope| |regulation of fertilization| |centrosome localization| |microtubule organizing center localization| |snRNA transcription by RNA polymerase II| |snRNA transcription| |flagellated sperm motility| |sperm motility| |mitotic spindle organization| |cilium-dependent cell motility| |ncRNA transcription| |cilium or flagellum-dependent cell motility| |microtubule cytoskeleton organization involved in mitosis| |spindle organization| |regulation of reproductive process| |protein localization to nucleus| |microtubule cytoskeleton organization| |transcription by RNA polymerase II| |cell division| |organelle localization| |mitotic cell cycle process| |regulation of mitotic cell cycle| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |microtubule-based process| |mitotic cell cycle| |protein localization to organelle| |regulation of multi-organism process| |cell cycle process| |cell motility| |localization of cell| |nucleobase-containing compound biosynthetic process| |cytoskeleton organization| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |regulation of cell cycle| |organic cyclic compound biosynthetic process| |locomotion| |cell cycle| |reproductive process| |reproduction| |movement of cell or subcellular component| |cellular protein localization| |cellular macromolecule localization| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|-2.64| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-2.32| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|-2.3| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|-2.09| |[[:results:exp436|Dynasore 7μM R08 exp436]]|-2.04| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|-1.94| |[[:results:exp128|GSK591 2.6μM R03 exp128]]|-1.94| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-1.89| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|-1.87| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|-1.84| |[[:results:exp467|CAY10603 0.55μM R08 exp467]]|-1.82| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|-1.82| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|1.72| |[[:results:exp532|TIC10 10μM R08 exp532]]|1.74| |[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|1.76| |[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|1.78| |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|1.86| |[[:results:exp380|NMS-873 0.07μM R07 exp380]]|1.89| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|1.97| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|2.02| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|2.04| |[[:results:exp474|CR131-b 0.005μM R08 exp474]]|2.07| |[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|2.11| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|2.21| |[[:results:exp67|BVD-523 15μM R02 exp67]]|2.23| |[[:results:exp492|iCRT14 30μM R08 exp492]]|2.26| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|2.3| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|2.35| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|2.36| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|2.43| |[[:results:exp85|UM0129480 7μM R02 exp85]]|2.45| |[[:results:exp431|Rotenone 0.07μM R08 exp431]]|2.54| |[[:results:exp211|AICAR 240μM R05 exp211]]|2.65| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|2.66| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|2.7| |[[:results:exp534|Trientine 500μM R08 exp534]]|2.85| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|2.95| |[[:results:exp134|MS023 2μM R03 exp134]]|2.96| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|2.97| |[[:results:exp135|MS023 7μM R03 exp135]]|3.07| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|3.2| |[[:results:exp116|AICAR 240μM R03 exp116]]|3.26| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|3.27| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|3.55| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|3.74| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|3.84| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|4.01| ^Gene^Correlation^ |[[:human genes:i:ints10|INTS10]]|0.843| |[[:human genes:c:c7orf26|C7orf26]]|0.819| |[[:human genes:v:vwa9|VWA9]]|0.602| |[[:human genes:u:urm1|URM1]]|0.479| |[[:human genes:m:mocs3|MOCS3]]|0.471| |[[:human genes:c:ctu1|CTU1]]|0.455| |[[:human genes:e:elp3|ELP3]]|0.405| |[[:human genes:a:acsl3|ACSL3]]|0.403| |[[:human genes:u:uba5|UBA5]]|0.401| |[[:human genes:m:mlst8|MLST8]]|0.4| Global Fraction of Cell Lines Where Essential: 7/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|1/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|1/75| |lymphocyte|0/16| |ovary|1/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|1/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2425 * **Expression level (log2 read counts)**: 5.9 {{:chemogenomics:nalm6 dist.png?nolink |}}